Bayer Cropscience · NSE: BAYERCROP · BSE: 506285
Q4 FY25 results · Jan–Mar 2025
Bayer Cropscience reported revenue from operations of ₹1,046.40 crore (up 32.2% from Q4 FY24) and net profit of ₹143.30 crore (up 49.3% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a standalone basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,046.40 | 791.50 | +32.2% | 1,056.90 | −1.0% |
| Other income | 37.10 | 29.60 | +25.3% | 32.70 | +13.5% |
| Total income | 1,083.50 | 821.10 | +32.0% | 1,089.60 | −0.6% |
| Profit before tax | 167.90 | 105.40 | +59.3% | 33.60 | +399.7% |
| Net profit for the period | 143.30 | 96.00 | +49.3% | 34.20 | +319.0% |
| EPS, basic (₹) | 31.88 | 21.36 | +49.3% | 7.61 | +318.9% |
| Net margin (%) | 13.7 | 12.1 | 3.2 |
Standalone
- Filed with BSE
- 26 May 2025, 19:12 IST
- Board meeting
- 26 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE